Valuation: Enovis Corporation

Market Cap 1.27B 1.11B 1.03B 959M 1.8B 120B 1.83B 12.3B 4.77B 58.93B 4.76B 4.65B 205B P/E 2026 *
181x
P/E 2027 * 22.8x
Enterprise Value 2.46B 2.16B 1.99B 1.86B 3.5B 233B 3.56B 23.93B 9.27B 115B 9.25B 9.05B 398B EV / Sales 2026 *
1.05x
EV / Sales 2027 * 0.95x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+2.95%
1 week+0.18%
Current month-2.95%
1 month-9.01%
3 months-2.70%
6 months-18.06%
Current year-17.38%
1 week 21.06
Extreme 21.06
22.54
1 month 20.55
Extreme 20.55
24.63
Current year 20.55
Extreme 20.55
29.89
1 year 20.55
Extreme 20.55
36.82
3 years 20.55
Extreme 20.55
66.14
5 years 20.55
Extreme 20.55
164.01
10 years 20.55
Extreme 20.55
164.01
Manager TitleAgeSince
Chief Executive Officer 61 11/05/2025
Director of Finance/CFO 47 31/12/2022
Chief Administrative Officer - 04/01/2026
Director TitleAgeSince
Director/Board Member 55 12/05/2008
Director/Board Member 67 20/09/2010
Chairman 64 20/05/2025
Date Insider Type Main position Quantity % Market Cap.
06-14Buy

Chief Administrative Officer

1,000 0.0017%
06-10Free

Chief Administrative Officer

1,000 0.0017%
06-10Buy

Chief Administrative Officer

1,200 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
+2.95%+0.18%-31.50%-63.23% 1.27B
+0.77%+2.70%-19.41%+6.12% 121B
-0.81%+1.16%+3.36%-8.15% 12.85B
+3.49%+9.10%+43.56%+111.31% 8.37B
+0.95%-2.64%-48.91%-71.79% 3.95B
-0.83%-0.59%+17.21%+37.73% 2.53B
+3.08%+21.07%+250.54%+185.59% 1.7B
-5.16%-4.93%-20.70%-17.36% 1.68B
-0.87%-0.70%-0.12%-20.99% 1.57B
Average +0.40%+2.14%+21.56%+17.69% 17.23B
Weighted average by Cap. +0.73%+2.73%-11.24%+10.02%

Financials

2026 *2027 *
Net sales 2.34B 2.06B 1.9B 1.77B 3.33B 221B 3.39B 22.77B 8.82B 109B 8.81B 8.61B 379B 2.47B 2.17B 2B 1.87B 3.5B 233B 3.57B 23.95B 9.28B 115B 9.26B 9.06B 399B
Net income 2.96M 2.6M 2.4M 2.24M 4.2M 279M 4.28M 28.74M 11.13M 138M 11.12M 10.87M 478M 54.22M 47.63M 43.88M 41.03M 76.95M 5.12B 78.36M 526M 204M 2.52B 204M 199M 8.76B
Net Debt 1.2B 1.05B 969M 906M 1.7B 113B 1.73B 11.63B 4.5B 55.69B 4.5B 4.4B 194B 1.07B 936M 863M 807M 1.51B 101B 1.54B 10.35B 4.01B 49.58B 4B 3.92B 172B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
25/06/26 US$22.01 +2.95% 747,461
24/06/26 US$21.38 +1.09% 1,225,468
23/06/26 US$21.15 -0.70% 873,382
22/06/26 US$21.30 -3.05% 1,097,599
18/06/26 US$21.97 +5.37% 1,799,377
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
22.01USD
Average target price
42.30USD
Spread / Average Target
+92.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock